In comparison, a study conducted by Tamam et al. revealed that male patients with MS were likely to have lower serum APOE levels and that the most common APOE genotype in patients with MS was ε3/ε3 (82.0%). The gene discussed is APOE; the disease is myeloid sarcoma.